Finally, mRNA vaccines against cancer are starting to become a reality
mRNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.
mRNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.
A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — diffuse midline gliomas.
It’s mRNA-based, the same technology Moderna used for its Covid-19 vaccine.
Scientists added peanut-protein to a toothpaste and tested it on adults with peanut allergies. Here's what happened next.
The clinical benefits are astonishing in some cases.
This is truly an exciting achievement.
The results are huge.